Loading…
Nephros, Inc. is projected to rise to $5.12 by 2027, a +46% move from its current price of $3.51. NEPH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.39 | $3.51 | $3.64 | +0.12% |
| Aug 6 | $3.34 | $3.52 | $3.70 | +0.25% |
| Aug 7 | $3.31 | $3.52 | $3.75 | +0.37% |
| Aug 8 | $3.28 | $3.53 | $3.79 | +0.50% |
| Aug 9 | $3.26 | $3.53 | $3.83 | +0.62% |
| Aug 10 | $3.24 | $3.54 | $3.86 | +0.75% |
| Aug 11 | $3.22 | $3.54 | $3.89 | +0.88% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.22 | $3.54 | $3.89 | +0.88% |
| Week 2 | $3.12 | $3.57 | $4.08 | +1.76% |
| Week 3 | $3.06 | $3.60 | $4.25 | +2.65% |
| Week 4 | $3.01 | $3.63 | $4.39 | +3.55% |
| Week 5 | $2.97 | $3.67 | $4.53 | +4.45% |
| Week 6 | $2.93 | $3.70 | $4.67 | +5.37% |
| Week 7 | $2.90 | $3.73 | $4.79 | +6.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nephros, Inc. is a commercial-stage company in the healthcare sector that develops and sells water filtration solutions for medical and commercial applications in the United States.
Its ultrafiltration products are used in dialysis centers to remove biological contaminants from water and bicarbonate concentrate, and in hospitals to prevent infection from waterborne pathogens such as legionella and pseudomonas.
The company also manufactures water filters that enhance taste and odor, reduce biofilm and scale, and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Nephros, Inc. (NEPH) trades around $3.50 per share and has a market capitalization of $38M, with a rank of 4396. The stock’s current price sits near the SMA50 of $3.49 while the SMA200 sits at $4.03, illustrating a closer near-term moving average vs. a longer-term benchmark.
The 30-day price range runs from $2.75 to $4.45, and the stock carries a neutral technical stance with RSI at 50, a support level at $3.15, and a resistance level at $3.78. Annualized volatility is high at 70%, underscoring substantial price swings over the period.
Forecasts show a bullish longer-term trajectory with the average price rising from $3.50 in 2026 to higher levels in subsequent years, reaching $41.32 on average by 2050. The outlook features substantial upside from 2027 onward, with Avg prices climbing through 2028–2050 and ROIs extending from 50.5 (2027) to 1080.5 (2050). Note that these figures are estimates and not guarantees.
A major floor 20.8% below — a decisive break under it would weaken the trend.
The nearest floor, 10.3% below — buyers have tended to step in here.
The nearest ceiling, 7.7% above — a clean break opens room to run.
A major ceiling 16.0% above — clearing it would confirm fresh momentum.
Key NEPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NEPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.41 | Buy | $3.44 | Buy |
| MA 10 | $3.54 | Sell | $3.50 | Buy |
| MA 20 | $3.56 | Sell | $3.51 | Sell |
| MA 50 | $3.49 | Buy | $3.47 | Buy |
| MA 100 | $3.30 | Buy | $3.53 | Sell |
| MA 200 | $4.02 | Sell | $3.63 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.43 | Neutral |
| Stoch RSI (14) | 27.59 | Neutral |
| CCI (20) | -93.90 | Neutral |
| Williams %R (14) | -72.22 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -6.87 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 27.78 | Neutral |
| TRIX (15) | 0.17 | Buy |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 42.18 | Neutral |
| Momentum (10) | -0.39 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 3.32 | Buy |
| ADX (14) | 9.95 | Neutral |
| ATR (14) | 0.12 | Info |
The near-term technical picture is neutral, with RSI14 at 50. The price is trading around the 50-day moving average of $3.49, while the 200-day moving average sits at $4.03, suggesting a tendency toward the shorter-term benchmark.
Support is identified at $3.15 and resistance at $3.78, framing a modest trading band around the current level. Over the last 30 days, the stock has traded between $2.75 and $4.45, reflecting notable intra-month volatility that can influence near-term moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.78 | $3.51 | $5.25 | 0% | Neutral | |
| $3.97 | $5.12 | $7.04 | +46% | Bullish | |
| $4.45 | $5.96 | $8.60 | +70% | Bullish | |
| $5.08 | $7.04 | $10.54 | +101% | Bullish | |
| $4.66 | $6.64 | $10.25 | +89% | Bullish | |
| $4.70 | $6.87 | $10.88 | +96% | Bullish | |
| $5.66 | $8.47 | $13.75 | +141% | Bullish | |
| $6.79 | $10.40 | $17.24 | +196% | Bullish | |
| $7.71 | $12.07 | $20.40 | +244% | Bullish | |
| $7.73 | $12.37 | $21.28 | +252% | Bullish | |
| $11.45 | $20.21 | $37.45 | +476% | Bullish | |
| $16.34 | $34.39 | $70.93 | +880% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.78 | $3.51 | $4.55 | +0.00% |
| September 2026 | $3.34 | $3.98 | $4.91 | +13.41% |
| October 2026 | $3.27 | $3.93 | $4.92 | -1.22% |
| November 2026 | $3.24 | $3.93 | $4.97 | +0.03% |
| December 2026 | $3.37 | $4.11 | $5.25 | +4.55% |
Click any year to see its month-by-month NEPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NEPH to range from $2.78 to $5.25 through 2026. The $3.51 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The NEPH price prediction for 2027 points to an average of $5.12 (low $3.97, high $7.04) — a potential gain of +46% on today's $3.51. Buyers look set to stay in control over this stretch.
In 2028, NEPH is projected to trade between $4.45 and $8.60, averaging $5.96 — a potential gain of +70% from today's $3.51. That is up +16% on the projected 2027 average. Momentum favours further upside here.
Nephros, Inc.'s 2029 outlook centres on $7.04, within a $5.08 to $10.54 range. That is up +18% on the projected 2028 average. That marks a +101% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, NEPH could reach as high as $10.25, with a base case around $6.64 and support toward $4.66 — roughly +89% from $3.51. Momentum favours further upside here.
Expect NEPH to range from $4.70 to $10.88 through 2031. The $6.87 average target implies a +96% move from current prices. That is up +3% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The NEPH price prediction for 2032 points to an average of $8.47 (low $5.66, high $13.75) — a potential gain of +141% on today's $3.51. Momentum favours further upside here.
In 2033, NEPH is projected to trade between $6.79 and $17.24, averaging $10.40 — a potential gain of +196% from today's $3.51. That is up +23% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Nephros, Inc.'s 2034 outlook centres on $12.07, within a $7.71 to $20.40 range. That is up +16% on the projected 2033 average. That marks a +244% change versus current levels. Momentum favours further upside here.
By 2035, NEPH could reach as high as $21.28, with a base case around $12.37 and support toward $7.73 — roughly +252% from $3.51. Buyers look set to stay in control over this stretch.
Expect NEPH to range from $11.45 to $37.45 through 2040. The $20.21 average target implies a +476% move from current prices. That is up +63% on the projected 2035 average. Momentum favours further upside here.
The NEPH price prediction for 2050 points to an average of $34.39 (low $16.34, high $70.93) — a potential gain of +880% on today's $3.51. Buyers look set to stay in control over this stretch.
Investing $1,000 in NEPH today (≈ 284.900285 NEPH) could be worth
$9,798.08
+$8,798.08 (+880%) by 2050 · US Dollar
Based on the average projected NEPH price of $34.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NEPHwould be worth at today's price.
$1,000 invested in NEPH on Jul 31, 2025 (≈ 281.690145 NEPH) would be worth
$988.73
-$11.27 (-1.1%) today · 0.99× · US Dollar
Based on a NEPH entry price of $3.55 vs. today's $3.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.64 | $964.29 | -3.6% |
| 1 month ago | $3.37 | $1,041.54 | +4.2% |
| 3 months ago | $3.11 | $1,128.62 | +12.9% |
| 6 months ago | $4.57 | $768.05 | -23.2% |
| 1 year ago | $3.55 | $988.73 | -1.1% |
| All time (5.0y) ago | $8.43 | $416.37 | -58.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NEPH forecast.
Our base-case forecast reaches $7.00 around 2029.
Implied market cap at $7.00: $76M
The multi-year forecast depicts a bullish trajectory from 2027 onward. The 2026 forecast shows an average of $3.50 with a 0 ROI, followed by 2027 at $5.27 average and 50.5 ROI, then 2028 at $6.21 average and 77.5 ROI, and 2029 at $7.44 average with 112.5 ROI.
By 2030 the forecast shows an average of $7.02 and ROI 100.5, continuing to 2031 with an average of $7.43 and ROI 112.3. The path extends into 2032 with an average of $9.46 and ROI 170.3, 2033 with $11.60 and ROI 231.6, 2034 with $13.52 and ROI 286.4, and 2035 with $13.97 and ROI 299.3.
The longer-range view accelerates markedly, with 2040 averaging $23.69 and ROI 577, and 2050 averaging $41.32 with ROI 1080.5. Across these years, the sentiment is consistently bullish, though real-world results will depend on market conditions, operating performance, and other factors outside this forecast.
Tap a question to reveal the answer.
In 2030, the average target price is $7.02, with a min of $4.91 and a max of $10.87. The forecast implies a ROI of 100.5 and a bullish sentiment for that year.
The outlook shows a neutral stance in 2026, followed by bullish sentiment from 2027 onward, with average prices rising to $5.27 (2027), $6.21 (2028), and ultimately to $41.32 average by 2050, with ROIs rising to 1080.5. These figures are estimates and not guarantees.
The forecast maximum for 2050 is $85.74, not $100. The 2050 max price is stated as $85.74 with a corresponding ROI of 1080.5.
The current price is $3.50.
The 30-day range is $2.75 to $4.45.
Nephros, Inc. Community Discussion
0Share your Nephros, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.